Figure 6

Effects of recombinant peptides on neuroblastoma cell viability with 6-OHDA. (a) The effect of 10 µM peptides on the viability of 6-OHDA-treated Neuro2a cells. (b) Dose-response effect of rHCIQ2c1 on Neuro2a cell viability. (c) Dose-response effect of rHCIQ2c1 on ROS formation into 6-OHDA-treated murine neuroblastoma cells. The influence of peptides on cell viability without 6-OHDA is shown in the white bar. * – p < 0.05.